Normal view MARC view ISBD view

Bayesian model averaging continual reassessment method for bivariate binary efficacy and toxicity outcomes in phase I oncology trials.

Asakawa, Takashi

Bayesian model averaging continual reassessment method for bivariate binary efficacy and toxicity outcomes in phase I oncology trials. [electronic resource] - Journal of biopharmaceutical statistics 2014 - 310-25 p. digital

Publication Type: Journal Article

ISSN: 1520-5711

Standard No.: 10.1080/10543406.2013.863779 doi

Subjects--Topical Terms:
Algorithms
Antineoplastic Agents--therapeutic use
Bayes Theorem
Clinical Trials, Phase I as Topic--methods
Humans
Neoplasms--drug therapy
Treatment Outcome

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)